Joined May 2011
1,248 Photos and videos
FDA Biologics retweeted
The FDA has released an updated public report on real-world evidence (RWE) submissions to the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) — now including data from Fiscal Year 2025!
2
6
13
3,676
Today, from 11 am – 12 PM ET, the Office of Therapeutic Products will host a virtual town hall with experts from OTP’s Office of Review Management & Regulatory Review answering questions regarding Biologic License Application readiness. fda.gov/vaccines-blood-biolo…
2
2
6
537
Today, the FDA published a draft guidance that when finalized will outline how sponsors can use publicly available information and established platform knowledge to streamline the development of cell and gene therapy products. fda.gov/news-events/press-an…
21
16
63
32,198
On Thursday June 4, 2026, from 11 am – 12 PM ET, the Office of Therapeutic Products will host a virtual town hall with experts from OTP’s Office of Review Management & Regulatory Review answering questions regarding Biologic License Application readiness. fda.gov/vaccines-blood-biolo…
3
8
11
4,689
FDA Biologics retweeted
⏱️REdI 2026 is here! Don't miss your opportunity to learn from FDA experts across all three medical product centers. Build your regulatory knowledge in drugs, devices, and biologics. Register and join today ➡️ fda.gov/news-events/regulato…
1
5
1,672
FDA Biologics retweeted
⏱️REdI 2026 is here! Don't miss your opportunity to learn from FDA experts across all three medical product centers. Build your regulatory knowledge in drugs, devices, and biologics. Register and join today ➡️ fda.gov/news-events/regulato…
2
5
1,834
FDA Biologics retweeted
🕒 There's still time to register! Secure your spot for the Regulatory Education for Industry Annual Conference 2026. Gain cutting-edge regulatory insights from FDA experts in drugs, devices, and biologics. 📝 Register now—don't miss this opportunity! ➡️ fda.gov/news-events/regulato…
1
3
4
2,173
FDA Biologics retweeted
🕒 There's still time to register! Secure your spot for the Regulatory Education for Industry Annual Conference 2026. Gain cutting-edge regulatory insights from FDA experts in drugs, devices, and biologics. 📝 Register now—don't miss this opportunity! ➡️ fda.gov/news-events/regulato…
4
7
1,976
FDA Biologics retweeted
🕒 There's still time to register! Secure your spot for the Regulatory Education for Industry Annual Conference 2026. Gain cutting-edge regulatory insights from FDA experts in drugs, devices, and biologics. 📝 Register now—don't miss this opportunity! ➡️ fda.gov/news-events/regulato…
1
6
1,742
FDA Biologics retweeted
⏱️REdI 2026 is approaching! Don't miss your opportunity to learn from FDA experts across all three medical product centers. Build your regulatory knowledge in drugs, devices, and biologics. 🗓️ Mark your calendar and register today ➡️ fda.gov/news-events/regulato…
1
1
6
1,537
FDA Biologics retweeted
This week, @FDACBER and @FDA_Drug_Info held an all-hands discussion on FDA's Plausible Mechanism Framework, featuring expert guests from @Penn and @broadinstitute. Topics included an update on Baby KJ, whose personalized CRISPR therapy inspired the framework, and researcher experiences with the IND & approval process. Watch the recording here: youtube.com/live/1OdI5_ls7vA
10
5
31
6,997
FDA Biologics retweeted
⏱️REdI 2026 is approaching! Don't miss your opportunity to learn from FDA experts across all three medical product centers. Build your regulatory knowledge in drugs, devices, and biologics. 🗓️ Mark your calendar and register today ➡️ fda.gov/news-events/regulato…
2
1
7
2,137
Join FDA via livestream for a discussion on the plausible mechanism guidance and its applicability to both CDER and CBER products: youtube.com/live/1OdI5_ls7vA…
8
6
13
12,366
The program will include special guests Rebecca Ahrens-Nicklas, MD, PhD, University of Pennsylvania, Lindsey A. George, MD, University of Pennsylvania, Kiran Musunuru, MD, PhD, University of Pennsylvania, and Sonia Vallabh, PhD, Broad Institute of MIT and Harvard.
2
1
556
We will also discuss an update on Baby KJ, whose personalized CRISPR-based gene-editing therapy for a severe urea cycle disorder inspired the Plausible Mechanism Framework, and share researcher experiences on IND clearance and the FDA approval process.
1
4
448
FDA Biologics retweeted
Apr 23
Today FDA approved the first-ever gene therapy for the treatment of genetic hearing loss under the National Priority Voucher Program. ✅6th approval under the National Priority Voucher Program ✅Approved 61 days after filing fda.gov/news-events/press-an…
29
46
205
41,043
New phenol-free formulation promises field deployment for disease surveillance and vaccine trials, eliminating cold-chain requirements for neglected tropical disease affecting 90 countries. sciencedirect.com/science?_o…
2
2
510
Today, the FDA issued a draft guidance that when finalized, will provide recommendations for standardized methods for sponsors developing human gene therapy products that incorporate genome editing technologies. fda.gov/news-events/press-an…
10
25
72
12,453
This guidance will provide sponsors with clear, scientifically grounded recommendations to bring effective treatments to patients sooner.
1
1
813
FDA Biologics retweeted
⏱️REdI 2026 is approaching! Don't miss your opportunity to learn from FDA experts across all three medical product centers. Build your regulatory knowledge in drugs, devices, and biologics. 🗓️ Mark your calendar and register today ➡️ fda.gov/news-events/regulato…
3
4
9
1,971